Rochester, NY (PRWEB) May 24, 2014
At-Risk teenage girls are more likely to develop an infection with HPV or herpes. The study “evaluated 861 female adolescents aged 12 to 19 years to determine rates of STIs among the population. Participants were included if they had ever engaged in vaginal or anal intercourse and intended to get or already received the quadrivalent HPV vaccine (Gardasil, Merck) (1).” The CDC defines “At-risk” as people who engage in “sexual risk behaviors that can result in unintended health outcomes.” (See the CDC, Last updated on August 26, 2013) (2). This is defined further as un-protected sex without the use of a condom, birth control pills, or having sex with 4 or more people over the course of one’s life (2). polyDNA recommends that parents of teenagers talk to their pediatricians about Gene-Eden-VIR and Novirin. The formula of these natural antivirals was shown to reduce symptoms of HPV and herpes (HSV) infections in two post-marketing clinical studies that followed FDA guidelines.
Results of the study found that “Chlamydia was the most commonly reported STI (31.8%); followed by HPV (6%); trichomoniasis (5.8%); gonnorhea(4.7%); genital warts (3.4%), genital herpes (2.3%); syphilis (1.6%); oral herpes (1.5%); perineal warts (1.1%); HIV (1.1%); pubic lice (1%); and perineal herpes (0.4%). Non-STI diagnoses including yeast or urinary tract infections were reported by 28 adolescents in the study (1).” Please note that the common viral diseases mentioned in the study were HPV and herpes. The formula of Gene-Eden-VIR and Novirin was shown in two post-marketing clinical studies to reduce symptoms associated with these viral infections.
HPV: “Infection with certain types of HPV - a group of many different viruses - is the main risk factor for cervical cancer and pre-cancer and for genital warts. There are 2 vaccines against HPV approved for use in the US: Cervarix protects against 2 types of HPV strongly linked to cervical cancer; Gardasil protects against those same 2 types, plus 2 others known to cause most cases of genital warts. To be effective, though, either vaccine should be given before a person becomes exposed to HPV.” (See Cancer.gov, from June 19, 2013) (3).
Genital Herpes: “The number of sexually active teens infected with genital herpes continues to grow each year, according to herpes statistics reports… Center for Disease Control herpes statistics reveal that one in every five teens … have genital herpes.” (See Teenhelp.com) (4).
In light of these findings, polyDNA recommends that parents of teens talk to their pediatricians about Gene-Eden-VIR and Novirin. The formula of these natural products was designed to help the immune system target the latent form of HPV and herpes (HSV).
Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (5).
Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.
Up to 70% of those studied reported a decrease in symptoms associated with CMV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (5).
Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.
A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (6).
To learn more about Novirin, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) STIs more common among at-risk adolescent females. Published May 20, 2014.
(2) CDC - Sexual Risk Behavior: HIV, STD, & Teen Pregnancy Prevention. Last updated on August 26, 2013.
(3) Cancer.org - Lower HPV Rates in Teen Girls Attributed to Vaccine. Published on June 20, 2013.
(5) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(6) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. http://www.cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.